olferatx.comCrawled Nov 16, 2026
Olfera develops olfactory-based solutions for treating brain diseases by targeting the olfactory system as a direct pathway to the brain.
Olfera, a Mountain View biopharmaceutical startup, secures a NASA STTR Phase I award to validate its olfactory brain-on-chip platform (OChip) in microgravity aboard the International Space Station. The project, in partnership with BioServe Space Technologies, aims to accelerate Parkinson’s disease research under the 2026B-I solicitation (ORBECON.2.T26B). The award supports testing the platform’s potential to study disease progression in space-based conditions.
The ISS National Lab has launched the Orbital Edge Accelerator to support early-stage space technology startups. This initiative aims to incubate companies developing innovations for space applications. The program provides resources and mentorship to accelerate startup growth in the aerospace sector.
The ISS National Lab and investors CIRI, E2MC, and Stellar Ventures have chosen six startups—Kall Morris, Magma Space, Melagen Labs, Olfera, Quantum Qool, and Raptor Dynamix—for the inaugural Orbital Edge Accelerator program. These companies will advance space-based research and technology development through the initiative. The program aims to support innovation in orbital applications and commercialization efforts.
The International Space Station (ISS) National Lab selects six startups for its Orbital Edge Accelerator Program. These companies will advance space-based research and technology development, leveraging the ISS as a testbed. The program partners with investors like Cook Inlet Region, Inc. (CIRI) and E2MC to support innovation in space applications.

Olfera specializes in biopharmaceutical solutions addressing neurological conditions.